We use cookies to enhance your experience, for analytics & personalisation. We share information about the use of our site with our trusted partners. If you click the "Accept" button you agree to having these cookies set on your device. By continuing to use our site, we assume that you consent to receive all necessary tracking cookies from us. You can adjust your browser settings to control cookies. Find out more here.

Transforming orthopaedic surgery

Southampton Science Park biosciences company Renovos has been named as the first to receive investment from the newly launched Ronald Furlong Fund, set up by charity Orthopaedic Research UK (ORUK).

The £140,000 investment will support the company as it seeks to solve unmet needs for patients with painful and debilitating bone and joint conditions. The announcement of this inaugural award comes after a meticulous national search during which start-ups were put through their paces by leading healthtech experts, HS. The final decision was taken by ORUK scientific and investment committees.

Renovos is a pioneer of new nanoclay gel technology which has the potential to transform orthopaedic surgery. The technology allows a 100x lower dose of regenerative therapeutic agent to be precisely delivered and localised to the sites where needed, fundamentally changing the way extremely powerful and sometimes harmful drugs are given around bone. The approach is being regarded as a step-change improvement in safety, efficacy and ease of use, as well as delivering reduced adverse events and complications compared with current orthopaedic interventions for both the ageing population and younger, active individuals.

Professor Richard OC Oreffo, Founder and CSO of Renovos said: “We are delighted to receive support from ORUK, which will aid the development of our next generation orthopaedic regenerative medicine solutions, harnessing nanoclay gels to deliver bone forming agents safely and cost effectively. The recognition arising from being the first ever start-up to be supported by ORUK will help enormously with our Series A funding round.”

Dr Arash Angadji, CEO of ORUK said: “We are the first charity supporting start-ups with a focus on musculoskeletal health in the UK. The Ronald Furlong Fund initiative will play an important role in assisting entrepreneurs and innovators to quickly turn ideas into reality, with measurable benefits for the entire healthcare ecosystem. I am delighted to welcome Renovos as ORUK’s first investment.”

Book a meeting space

We have 11 meeting rooms all of which can be configured in a number of different ways to cater for your meeting or event. Please use the two links below to book a meeting room either as a tenant or a visitor to the University of Southampton Science Park

By booking through MIDAS you accept our Terms & conditions which can be viewed here.